Visible Light Response Photocatalytic Performance of Z-Scheme Ag3PO4/GO/UiO-66-NH2 Photocatalysts for the Levofloxacin Hydrochloride

A Ag3PO4/GO/UiO-66-NH2(AGU) composite photocatalyst was prepared by an ultrasonic-assisted in situ precipitation method. The optical property, structure, composition, and morphology of photocatalysts were investigated using UV-vis diffuse reflectance spectroscopy, photoluminescence spectroscopy, electrochemical impedance spectroscopy, X-ray diffraction, X-ray photoelectron spectroscopy, scanning electron microscopy, energy-dispersive spectrometry, transmission electron microscopy, Fourier transform infrared spectroscopy, and charge flow tracking by photodeposition of Pt and PbO2 nanoparticles. In comparison with Ag3PO4 and Ag3PO4/UiO-66-NH2(AU), the AGU composite photocatalyst showed heightened photocatalytic performance for the degradation of levofloxacin hydrochloride (LVF). The AGU photocatalyst (dosage: 0.8 g/L) with 1% mass content of graphene oxide (GO), the mass ratio of Ag3PO4 and UiO-66-NH2(U66N) reached 2:1, showed the highest photodegradation rate of 94.97% for 25 mg/L LVF after 60 min of visible light irradiation at pH = 6. The formation of a heterojunction and the addition of GO synergistically promote faster separation of electron-hole pairs, retain more active substances, and enhance the performance of the photocatalyst. Furthermore, the mechanism of the Z-scheme of the AGU composite photocatalytic is proposed.

Automated summary

An AG3PO4/GO/UiO-66-NH2 (AGU) composite photocatalyst was prepared by an ultrasonic-assisted in situ precipitation method. Compared to individual Ag3PO4 and Ag3PO4/UiO-66-NH2 (AU) photocatalysts, the AGU composite showed enhanced photocatalytic performance for the degradation of levofloxacin hydrochloride (LVF). The synergistic effects of heterojunction formation and the addition of graphene oxide (GO) in promoting faster separation of electron-hole pairs led to improved performance of the photocatalyst.